
Company Info
Year Established2025
Contacts
Elena Cant, Ph..D.Founder & CEO
Company Description
DetellaDx is developing screening and diagnostic solutions for early detection of ovarian cancer at Stage I when it is still a treatable disease.

DetellaDx is developing screening and diagnostic solutions for early detection of ovarian cancer at Stage I when it is still a treatable disease.